Overview

Hydroxychloroquine in Graves' Orbitopathy

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This study is aimed to investigate the effect of hydroxychloroquine in patients with mild and moderate-to-severe Graves' orbitopathy (GO).
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Hydroxychloroquine